Researchers discover new genetic markers linked to increased risk of glaucoma

The investigation studied the genetic make up of about 40,000 people and identified five previously unknown genetic areas linked to an increased risk of primary angle closure glaucoma (PACG).

Co-author of the study Professor Jamie Craig from Flinders University in South Australia said PACG symptoms occurred quickly and required immediate medical attention.

“This new discovery provides a handle, to gain an understanding of the mechanisms of the disease. This will help to work out who is at risk of developing angle closure glaucoma so they can have preventative laser treatment before an emergency situation develops,” Prof Craig said.

“We also expect in time, that the improved understanding of the pathways of this disease to lead to new ways to more effectively prevent and treat this serious condition, so that permanent loss of vision does not occur.”

The genetic analysis is by far the largest genome wide association study to date on this condition. It used a combined total of 10,404 cases of angle closure glaucoma and 29,343 normal controls to identify five novel glaucoma markers…

Source: http://www.theleadsouthaustralia.com.au/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study identifies DNA collisions driving genetic changes in cancer